23-Year-Old's 'Simple Ulcer' Led to Tongue Removal: Why Early Detection Saves Lives
A young woman’s story underscores the critical importance of oral cancer screening in patients of all ages.
THE NUMBERS TELL A SOBERING STORY:
• 1 in 5 oral cancer cases now occur in people under age 55
• Young adult oral cancer (under 44) has shown a significant increase in recent years
• Stage 1 oral cancer: 80-85% five-year survival rate
• Stage 4 oral cancer: only 20-30% five-year survival rate
• The survival difference between early and late detection can be more than 60 percentage points
WHEN A MOUTH ULCER ISN'T JUST AN ULCER
Jessica Tappenden-Rowell thought she knew what was happening when a lesion appeared under her tongue last May. At 23 years old, with no traditional risk factors like smoking or heavy alcohol use, she dismissed it as a stress-related mouth ulcer. She was wrong.
“It just started getting weirder, there was redness and there were white bumps around it,” Jessica explained. “I could see that it was getting worse. It didn’t even cross my mind that it would be something bad.”
What Jessica expected to be a simple prescription turned into a devastating diagnosis: squamous cell carcinoma, the most common type of oral cancer. Within months, she underwent extensive surgery to remove her tongue, which was then reconstructed using a skin graft from her tattooed forearm.
Her message to others is clear and urgent: “If you have an ulcer that has not gone away within two weeks, get it checked. The earlier you go, the less chance of this type of surgery. If I had gone earlier, I might not have needed such a large portion of my tongue removed.”
THE CLINICAL REALITY: YOUNG ADULTS ARE NOT IMMUNE
Jessica’s case represents a growing trend that challenges the traditional demographic profile of oral cancer patients. While the median age of diagnosis remains 64, research shows that young adult oral cancer incidence is rising, particularly among women. Recent epidemiological studies reveal that approximately 20% of all oral and oropharyngeal cancer cases occur in people younger than 55.
This shift has profound clinical implications:
• Risk assumptions must change: Young, healthy patients without traditional risk factors can develop aggressive oral cancers
• Symptoms can be subtle: Early lesions may appear identical to common benign conditions like aphthous ulcers
• Time is critical: The progression from a small, localized tumor to advanced disease can occur within months
• Outcomes vary dramatically by stage: Early detection offers an 80-85% five-year survival rate, while late-stage detection drops to 20-30%
WHAT THIS MEANS FOR YOUR PRACTICE
Jessica’s surgeon confirmed what the data shows: her cancer had not been caused by lifestyle factors. “Even if you had been a severe alcoholic and smoker, at your age this would not have done anything to you yet,” he told her. The cause? In her words, “just bad luck.”
But early detection is not a matter of luck. It’s a matter of systematic screening.
Research published in the Journal of Oncology demonstrates that routine dental visits provide frequent opportunities to detect oral cancer at earlier stages. Regular dental care is associated with improved survival from oral cancer, while infrequent dental care correlates with higher incidence rates of advanced disease.
The clinical implications are straightforward:
• Visual examination alone cannot reliably differentiate between benign and malignant lesions in their earliest stages
• Any non-healing oral lesion persisting beyond two weeks warrants further investigation
• Earlier detection directly correlates with less invasive treatment and significantly better outcomes
• Young patients may present with atypical risk profiles, making age-based screening criteria insufficient
ENHANCED DETECTION: A PRACTICE ADVANTAGE
VELscope technology addresses the fundamental challenge Jessica’s case illustrates: identifying suspicious lesions before they progress to advanced stages requiring devastating interventions.
The tissue fluorescence visualization system enables practitioners to:
• Identify abnormal tissue that may not be visible under white light examination
• Detect dysplastic changes in their earliest stages
• Provide immediate visual feedback during routine examinations
• Document baseline tissue patterns for comparison over time
This is not about replacing clinical judgment or biopsy protocols. VELscope serves as an adjunctive tool that enhances your existing examination, helping you identify lesions that warrant closer monitoring or referral before they progress to the stage that required Jessica to undergo such extensive, life-altering surgery.
THE BUSINESS CASE: PREVENTION OVER INTERVENTION
Consider the timeline in Jessica’s case:
• Initial lesion appears (likely caught during routine exam with enhanced screening)
• Several weeks of observation as symptoms worsen (critical detection window)
• Medical consultation and referral
• Biopsy confirmation of malignancy (already progressed)
• Major surgical intervention required
Now consider an alternative scenario with enhanced early detection:
• Suspicious tissue changes identified during routine dental visit
• Immediate referral for biopsy based on screening findings
• Earlier-stage diagnosis
• Less invasive treatment with better outcomes
For your practice, implementing adjunctive screening technology represents:
• Enhanced patient care: The ability to catch potentially life-threatening conditions at their most treatable stages
• Practice differentiation: Advanced diagnostic capabilities that set your practice apart
• Risk management: Systematic protocols for identifying and documenting suspicious lesions
• Patient education opportunities: Visual demonstration of oral health status and screening value
• Revenue enhancement: Billable screening procedures integrated into preventive care protocols
JESSICA'S JOURNEY: MONTHS OF RECOVERY THAT MIGHT HAVE BEEN PREVENTED
Following her surgery, Jessica spent months relearning how to speak. “When it came to speaking I was really slurred and really slow because everything in my mouth was so swollen and my tongue muscle was a lot weaker,” she explained. “It took me months” to speak normally again.
Today, she still struggles with eating and experiences ongoing challenges. “I still have some days where I struggle a bit. If my mouth is extra tired, if I’ve been talking quite a lot, then I get even more slurry just because my muscles in my tongue are not the same.”
While she’s now cancer-free, the permanent impact on her quality of life is profound. Her surgeon acknowledged what the statistics confirm: earlier detection would likely have meant preserving more of her tongue and avoiding such extensive reconstruction.
MAKE EARLY DETECTION YOUR PRACTICE STANDARD
Every patient deserves the advantage of enhanced oral cancer screening.
VELscope technology helps you identify suspicious tissue changes that may not be visible to the naked eye, giving you and your patients the critical advantage of earlier detection.
Learn how VELscope can integrate into your practice’s preventive care protocols and help you deliver the early detection that saves lives, preserves function, and improves outcomes.
Contact us today to schedule a demonstration and discover how enhanced screening can become your practice’s standard of care.
Call 1-888-658-5231
Visit: velscopeshop.com/contact
—
References:
American Cancer Society. Cancer Facts & Figures 2026. Oral Cavity and Oropharyngeal Cancer Key Statistics.
Lenoci D, et al. (2024). Oral cancer in young adults: incidence, risk factors, prognosis, and molecular biomarkers. Frontiers in Oncology.
National Cancer Institute SEER Program. Cancer Stat Facts: Oral Cavity and Pharynx Cancer.
NIDCR. Oral Cancer 5-Year Survival Rates by Race, Sex, and Stage of Diagnosis.